SCHEMBL7709659

SCHEMBL7709659

O=C1c2ccc(N3CCCCC3)c3cc(Br)cc(c23)C(=O)N1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.49
MEN1 O00255 11/20 0.49
LMNA P02545 5/20 0.49
POLB P06746 5/20 0.49
USP2 O75604 3/20 0.49
HTT P42858 6/20 0.47
ALDH1A1 P00352 5/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
TLR9 Q9NR96 2/20 0.47
TNNI3 P19429 1/20 0.47
TNNT2 P45379 1/20 0.47
TNNC1 P63316 1/20 0.47
MAPT P10636 7/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
AVPR1A P37288 1/20 0.47
TSHR P16473 4/20 0.45
CASP1 P29466 2/20 0.45
HBB P68871 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709788 0.99 KMT2A (0.47) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7703800 0.82 KMT2A (0.45) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7709609 0.80 KMT2A (0.69) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7972269 0.79 KMT2A (0.46) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7709797 0.79 KMT2A (0.67) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7706867 0.78 MEN1 (0.47) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7709502 0.77 POLB (0.40) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7706694 0.77 MEN1 (0.44) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL7709710 0.76 MEN1 (0.47) KMT2AMEN1LMNAPOLBUSP2
SCHEMBL8580196 0.74 TDP1 (0.44) KMT2AMEN1LMNAPOLBUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362181-B1 BACTERICIDES; ENZYME INHIBITORS; ANTITUMOR AGENTS WARNER-LAMBERT COMPANY 2002-03-26 US claimed
US-6177423-B1 N-(HYDROXY OR PROTECTED HYDROXY)-BENZO(DE)ISOQUINOLINE-1,3-DIONE DERIVATIVES; BACTERIAL DNA GYRASE AND DNA TOPOISOMERASE INHIBITORS USEFUL FOR ANTIBACTERIAL AGENTS HAVING REDUCED DRUG RESISTANCE AND REDUCED SIDE EFFECTS WARNER-LAMBERT COMPANY 2001-01-23 US claimed
EP-0939754-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1999-09-08 EP claimed
WO-1998019648-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1998-05-14 WO claimed
US-6362181-B1 BACTERICIDES; ENZYME INHIBITORS; ANTITUMOR AGENTS WARNER-LAMBERT COMPANY 2002-03-26 US disclosed
US-6177423-B1 N-(HYDROXY OR PROTECTED HYDROXY)-BENZO(DE)ISOQUINOLINE-1,3-DIONE DERIVATIVES; BACTERIAL DNA GYRASE AND DNA TOPOISOMERASE INHIBITORS USEFUL FOR ANTIBACTERIAL AGENTS HAVING REDUCED DRUG RESISTANCE AND REDUCED SIDE EFFECTS WARNER-LAMBERT COMPANY 2001-01-23 US disclosed
EP-0939754-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1999-09-08 EP disclosed
WO-1998019648-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1998-05-14 WO disclosed